Mechanisms of response and resistance to Olaparib and Durvalumab in treatment of glioblastomas and IDH-mutated astrocytomas Glioblastoma multiforme and high grade astrocytomas are aggressive brain tumors that are difficult to treat. Grant type Capacity building grants Area of Research Cancer Competition Henry and Berenice Kaufmann Foundation Trainee Award in Brain Cancer Research Province Ontario Start Date 2023
